openPR Logo
Press release

Long-Term Investors in shares of Edwards Lifesciences Corporation (NYSE: EW) should contact the Shareholders Foundation in connection with Investigation

An investigation on behalf of current long term investors in Edwards Lifesciences Corporation (NYSE: EW) shares.

An investigation on behalf of current long term investors in Edwards Lifesciences Corporation (NYSE: EW) shares.

An investigation was announced for current long-term investors in shares of Edwards Lifesciences Corporation (NYSE: EW) concerning potential breaches of fiduciary duties by certain directors and officers of Edwards Lifesciences Corporation.

Investors who are current long term investors in Edwards Lifesciences Corporation (NYSE: EW) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NYSE: EW stocks follows a lawsuit filed against Edwards Lifesciences Corporation over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE: EW stocks, concerns whether certain Edwards Lifesciences Corporation directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges that the defendants created the false impression that they possessed reliable information pertaining to Edwards Lifesciences' projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations, that TAVR's growth was at risk of decelerating, that Edwards Lifesciences' optimistic reports of TAVR's growth and anticipated ramp in second quarter 2024 and further ramp throughout fiscal year 2024 fell short of reality as defendants' "patient activation activities" failed to reach the perceived low-treatment-rate population TAVR's growth relied upon obtaining, and that the defendants relied far too heavily or otherwise overstated hospital desire to continue to utilize Edwards Lifesciences' TAVR procedures over newer, innovative structural heart therapies.

Those who purchased shares of Edwards Lifesciences Corporation (NYSE: EW) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Long-Term Investors in shares of Edwards Lifesciences Corporation (NYSE: EW) should contact the Shareholders Foundation in connection with Investigation here

News-ID: 3940408 • Views:

More Releases from Shareholders Foundation, Inc.

Ready Capital Corporation (NYSE: RC) Long Term Investor Investigation of potential Wrongdoing
Ready Capital Corporation (NYSE: RC) Long Term Investor Investigation of potenti …
An investigation was announced for potential breaches of fiduciary duties by certain directors and officers of Ready Capital Corporation. Investors who are current long term investors in Ready Capital Corporation (NYSE: RC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: RC stocks follows a lawsuit filed against Ready
Investigation announced for Long-Term Investors in shares of Digimarc Corporation (NASDAQ: DMRC) over possible Wrongdoing
Investigation announced for Long-Term Investors in shares of Digimarc Corporatio …
An investigation was announced for current long-term investors in shares of Digimarc Corporation (NASDAQ: DMRC) concerning potential breaches of fiduciary duties by certain directors of Digimarc Corporation. Investors who are current long term investors in Digimarc Corporation (NASDAQ: DMRC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: DMRC
Ultra Clean Holdings, Inc. (NASDAQ: UCTT) Investor Alert: Deadline in Lawsuit on May 23, 2025
Ultra Clean Holdings, Inc. (NASDAQ: UCTT) Investor Alert: Deadline in Lawsuit on …
A deadline is coming up on May 23, 2025 in the lawsuit filed for certain investors of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) over alleged securities laws violations by Ultra Clean Holdings, Inc. Investors who purchased shares of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) have certain options and there are strict and short deadlines running. Deadline: May 23, 2025. Ultra Clean Holdings, Inc. (NASDAQ: UCTT) stockholders should contact the Shareholders
Lawsuit filed for Investors who lost money with shares of West Pharmaceutical Services, Inc. (NYSE: WST)
Lawsuit filed for Investors who lost money with shares of West Pharmaceutical Se …
An investor, who purchased shares of West Pharmaceutical Services, Inc. (NYSE: WST), filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania over alleged violations of Federal Securities Laws by West Pharmaceutical Services, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of West Pharmaceutical Services, Inc. (NYSE: WST) have certain options and for certain investors are short and strict deadlines running.

All 5 Releases


More Releases for Edwards

Vascular Access Devices Market 2019 Industry Trend, Types and Precise Outlook by …
The Global Vascular Access Devices Industry estimate the increasing prevalence of lifestyle diseases is driving the market growth. However high cost of maintenance might hamper the market growth. Vascular Access Devices Market 2019-2026 provides a detailed analysis by the categorization of the global market on the basis of regions. Also highlights the exhaustive study of the major market along with present and forecast industry scenario with useful business decision. Vascular Access Devices
JD EDWARDS USERS LIST - B2B Scorpion
Limiting your business idea and market is not an option. Because, you can get more, by expanding your business to the global platform. For that, we, the B2B Scorpion, have the right raw materials, using which you can opt for a better future projection. Use our JD Edwards Users list and take your business to a new level. We pursue this high performance driven List of JD Edwards Customers to
Global Molecular Pump Market 2017 - Ebara, Edwards, Busch, Leybold
Apex Market Reports, recently published a detailed market research study focused on the "Molecular Pump Market" across the global, regional and country level. The report provides 360° analysis of "Molecular Pump Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Molecular Pump industry, and estimates the future trend of Molecular Pump market
Sandra Edwards to Speak at TOC Annual Institute
ARLINGTON, VA – March 9, 2012 – The American Management Association (AMA) Enterprise Solutions, the global leader of talent transformation dedicated to providing workplace learning for enterprise and government organizations, has announced that their Senior Vice President, Sandra Edwards, has been chosen to speak about succession planning at the 2012 Training Officers Consortium (TOC) Annual Institute, to be held April 22-25 in Ocean City, MD. Ms. Edwards has over twenty years
Experts to Analyze the Value of JD Edwards Analytics
Panelists will explore Oracle's strategic direction For JDE Reporting in a simulcasted event. Atlanta, GA, January 12, 2012 -- Representatives from Oracle and KPI Partners today announced plans to host an educational event titled, 'JD Edwards Analytics - Proof of Value Event'. The session will be presented in-person at Oracle's office in Atlanta and streamed live over the internet. “Our goal with this event is to help current JD Edwards users gain
JDEtips Launches Webucation Series to Share JD Edwards Knowledge
Denver, CO – May 2, 2011 – JDEtips, a JD Edwards education and training provider, announced that they have launched a new program: “JDEtips Webucation” that will focus on JD Edwards knowledge transfer. The free lunchtime webcasts will run approximately 30 to 60 minutes and will cover advanced tips and best practices that will help JDE clients maximize the value of their JD Edwards software investment. Registrations for the live